Concepedia

István Tombácz

IT

12

Publications

2.4K

Citations

11

H-Index

2009

Active since

Affiliations

University of Pennsylvania(Current)

Acuitas Therapeutics (Canada)

Duke University

BioNTech (Germany)

Bioqual

István Tombácz is an author at University of Pennsylvania specializing in medicine, gene expression, and transcriptional regulation.

ORCID

Top concepts

Publications per year

2009–2023

12

Publications

12

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

Mohamad‐Gabriel Alameh, István Tombácz, Emily Bettini et al. · Immunity · 2021 · 659 citations · Full text

, , +11

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

Norbert Pardi, Michael J. Hogan, Martin S. Naradikian et al. · The Journal of Experimental Medicine · 2018 · 501 citations · Full text

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

Dorottya Laczkó, Michael J. Hogan, Sushila A. Toulmin et al. · Immunity · 2020 · 376 citations · Full text

, , +8

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

István Tombácz, Dorottya Laczkó, Hamna Shahnawaz et al. · Molecular Therapy · 2021 · 239 citations · Full text

Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier

Oscar A. Marcos‐Contreras, Colin F. Greineder, Raisa Y. Kiseleva et al. · Proceedings of the National Academy of Sciences · 2020 · 169 citations · Full text

Rows per page

1–5 of 12